graphic
News > Deals
Dr. Reddy's up 6c in debut
April 11, 2001: 11:24 a.m. ET

Indian pharmaceutical firm gains 6c to $10.10 in NYSE debut
graphic
graphic graphic
graphic
NEW YORK (CNNfn) - Dr. Reddy's Laboratories Ltd., an Indian pharmaceutical company, gained only 6 cents in its first day of trade Wednesday on the New York Stock Exchange.

Dr. Reddy's hit a high of $10.25 and then fell, closing at $10.10.

graphicDr. Reddy's sold 11.5 million American depositary shares at $10.04 each through underwriters led by Merrill Lynch. Each ADS represents 1/2 of an equity share. Dr. Reddy also trades on the Mumbai (Bombay) Stock Exchange and the National Stock Exchange in India.

Hyderabad, India-based Dr. Reddy's (RDY: Research, Estimates) makes and develops generic drugs and pharmaceuticals in India and exports its products to 60 countries. Brands include Omez, Nise, Stamlo and Enam. Dr. Reddy's also does drug research and has several products in development to treat diabetes, cancer and pain management through its research foundation.

Last May, Dr. Reddy's Labs acquired Cheminor Drugs, making it the third-largest pharmaceutical firm in India. graphic





graphic

© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.